0001185185-17-002086.txt : 20170929 0001185185-17-002086.hdr.sgml : 20170929 20170929172226 ACCESSION NUMBER: 0001185185-17-002086 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170929 DATE AS OF CHANGE: 20170929 EFFECTIVENESS DATE: 20170929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: America Great Health CENTRAL INDEX KEY: 0001098009 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980178621 STATE OF INCORPORATION: CA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27873 FILM NUMBER: 171112414 BUSINESS ADDRESS: STREET 1: 1609 W VALLEY BLVD UNIT 338A CITY: ALHAMBRA STATE: CA ZIP: 91803 BUSINESS PHONE: (626) 576-1299 MAIL ADDRESS: STREET 1: 1609 W VALLEY BLVD UNIT 338A CITY: ALHAMBRA STATE: CA ZIP: 91803 FORMER COMPANY: FORMER CONFORMED NAME: CROWN MARKETING DATE OF NAME CHANGE: 20111006 FORMER COMPANY: FORMER CONFORMED NAME: SPACE LAUNCHES FINANCING INC DATE OF NAME CHANGE: 19991028 NT 10-K 1 americahealth-nt10k063017.htm NT 10-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 

FORM 12b-25
 
NOTIFICATION OF LATE FILING
 

☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR

For the Period Ended: June 30, 2017
 
☐ Transition Report on Form 10-K
☐ Transition Report on Form 10-Q
☐ Transition Report on Form 20-F
☐ Transition Report on Form N-SAR
☐ Transition Report on Form 11-K

For the Transition Period Ended:                                               

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:                                                    
 
PART I - COMPANY INFORMATION
 
America Great Health
 
Full Name of Registrant
 
 
 
Crown Marketing
 
Former Name if Applicable
 
 
 
1609 W. Valley Blvd., #338
 
Address of Principal Executive Office (Street and Number)
 
 
 
Alhambra, CA 91803
 
City, State and Zip Code
 
 
PART II - RULES 12b-25 (b) and (c)
 
If the subject report could not be filed without reasonable effort or expense and the Company seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 
☒
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable
effort or expense;
 
 
 
☒
(b)
The subject annual report or semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form
N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date;
or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the
 fifth calendar day following the prescribed due date; and
 
 
 
☐
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable
 
PART III - NARRATIVE
 
The Company has not been able to compile the requisite financial data and other narrative information necessary to enable it to complete the Company's Annual Report on Form 10-K by September 28, 2017 without unreasonable effort and expense.
 
PART IV - OTHER INFORMATION
 
(1) Name and telephone number of person to contact in regard to this notification:

 
Mike Wang
 (626)
576-1299
(Name)
 (Area code)
(Telephone Number)
 
(2) Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company act of 1940 during the preceding 12 months or for such shorter period that the Company was required to file such report(s) been filed? If the answer is no, identify report(s).     ☒ Yes   ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof     ☐Yes    ☒ No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The Company has caused this notification to be signed on its behalf by the undersigned, thereunto duly authorized.

  
  
                             Date: September 28, 2017                                     
 
 America Great Health
By:  /s/Mike Wang
Mike Wang
                                                                                                                    
 President